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WALSURA ROBUSTA ROXB.: A ROBUST TREE
The plant genus Walsura comprises about 50 different names 
but there are only 4 accepted specie names: W. pinnata Hassk., 
W. trichostemon Miq., W. villosa Wall. ex Hiern. and W. robusta 
Roxb (http://www.theplantlist.org). There are other commonly 
used names, such as W. cochinchinensis (Baill.) Harms and W. 
yunnanensis C.Y. Wu but they are both synonyms for Walsura 
pinnata Hassk. These plants, belonging to the Meliaceae family, 
are usually found in subtropical regions of Southern China, 
India, Indonesia, and the Asean member countries.
The specie Walsura robusta Roxb. (synonym: Surwala robusta 
(Roxb.) M. Roem.) is an evergreen large tree which can usually 
grow 20-30 meters tall, with large leaves (Fig. 1). The outer bark 
is grey-brown whereas the inner bark is pink-red, with a specific 
wood anatomy. The wood of W. robusta presents a much larger 
vessel pore density (308/sq.mm) than the wood of W. trifoliolata, 
W. tubulata, and W. chrysogyne (at 81-154/sq.mm). The fruits 
of W. robusta Roxb. are non-edible, in contrast to those of W. 
pinnata Hassk. which are sweet-tasting brown-orange fleshy 
berries. From a taxonomic point of view, W. robusta belongs to 
a distinct subgroup compared to other Walsura species (Clark, 
1994). The tree can be found found in south-east Asia, notably 
in Vietnam (where it is called lòng tong), Cambodia, Thailand, 
Laos, Myanmar, and Malaysia. There is an old mention that the 
tree is commonly grown in Chittagong (Ghosh, 1968) and in the 
Rajkandi reserve forest of Moulvibazar, (Bangladesh) (Haque 
et al., 2018). There may be confusion about the name of the 
plant because several studies mention that the vernacular Bengla 
name for W. robusta in is bonlichu (or bonlichi), whereas other 
studies refer to bonlichu as a totally different tree, Xerospermum 
laevigatum Radlk. (Pasha and Uddi, 2019; Abdullah et al., 2020). 
W. robusta Roxb. is found also in the south of China, notably 
in the Yunnan, Guangxi, Guangdong, and Hainan provinces 
(Sakkatat, 2007).
EXTRACTS OF WALSURA ROBUSTA ROXB. AND 
THEIR USES
There are a few reports mentioning the traditional use of extracts 
of W. robusta Roxb. to treat various diseases and conditions. In 
Thailand, extracts of the leaves and twigs of the plant (called 
bonlichu) are used to treat microbial infections and diarrhea. 
In China, it may be named name “gesheshu” as mentioned in a 
study (Hou et al., 2013), although it is possible that this Chinese 
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The plant Walsura robusta Roxb. (Meliaceae) is a robust tree largely distributed in south-east Asia, including provinces 
of southern China. A few traditional usages of the plant have been mentioned, notably for the treatment of microbial 
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treatment of diseases with a cell proliferation component.
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name refers in fact to W. yunnanensis, as cited in another study 
(Luo et al., 2006). W. robusta seem to be used in traditional 
medicine in diverse countries in Asia, but there is a lack of 
robust information about this traditional usage. Moreover, there 
is also little experimental evidence to support the traditional 
medicinal use of W. robusta. Initially, a modest antibacterial 
activity was reported with an ethanolic plant extract found to 
inhibit the growth of a clinical isolate of methicillin-resistant 
Staphylococcus aureus (MRSA) and the S. aureus ATCC strain 
25923 with a minimum inhibitory concentration (MIC) of 
1.6 mg/ml (Voravuthikunchai and Kitpip, 2005a, 2005b). 
A better level of activity was observed using wood extracts of 
the plant against the enterohaemorrhagic Escherichia coli strain 
O157:H7, with MIC of 0.09 and 0.19 mg/ml for the aqueous 
and ethanolic extracts, respectively (Voravuthikunchai et al., 
2004) but a later study reported a marginal bacteriostatic and 
bactericidal activities with a similar extract (Voravuthikunchai 
and Limsuwan, 2006). In another study, an aqueous extract of 
W. robusta was found to mildly inhibit the growth of Gram-
positive and some Gram-negative bacteria, including E. coli. In 
the same study, the plant extract was tested against trophozoites 
of the intestinal parasite Giardia intestinalis but no anti-giardial 
activity was observed (Voravuthikunchai et al., 2010). Clearly, 
there is not enough experimental data to support the traditional 
use of the plant as an anti-infectious agent.
PHYTOCHEMICAL ANALYSES OF WALSURA 
ROBUSTA ROXB.
Diverse types of secondary metabolites have been isolated from 
W. robusta, in particular limonoids which are heavily oxygenated, 
modified triterpenes frequently encountered in Meliaceae and 
Rutaceae (Citrus species) and to a lesser extent in Cneoraceae 
and Simaroubaceae (Tan and Luo, 2011; Tundis et al., 2014; 
Zhang and Xu, 2017). The major limonoids in W. robusta are 
named walsuronoids A-C, initially isolated from the leaves of 
the plant (Yin et al., 2007). Walsuronoid A (Fig. 2) bears a seco 
limonoid skeleton with a 3,4-peroxide bridge and walsuronoids 
B and C possess an 18(13→14)-abeo-limonoid skeleton. 
Walsuronoid C has been considered as an oxidation product 
of walsuronoid B because its furyl ring is easily oxidized when 
exposed to air in chloroform. A modest growth inhibition of 
the malaria parasite Plasmodium falciparum was observed with 
walsuronoids A and B (40% inhibition at the dose of 40 µM) 
(Yin et al., 2007). Walsuronoid B was also identified from the 
fruits of the plant together with a series of linonoids, known 
as walsuronoid F-I and walsurins A-E (Fig. 2) and many other 
terpenoids (Zhang et al., 2017).
Walsuronoid B deserves a special mention because it has been 
shown to exert potent anticancer effects in vitro and in vivo 
(Geng et al., 2017). The compound dose-dependently inhibited 
the proliferation of several types of cancer cells, with IC50 in the 
range of 3-4 µM. Walsuronoid B blocked cell cycle progression 
of HepG2 and Bel-7402 liver cancer cells (G2/M arrest), with 
a concomitant up-regulation of cyclin B1 and down-regulation 
of (phospho)-cdc55C. The compound was found to trigger a 
massive apoptosis of these malignant cells, with activation of 
caspases and a drug-induced dysfunction of mitochondria and 
lysosomes (Fig. 3a). The molecular target of the drug is not 
known at present, but the compound enhanced the production 
of reactive oxygen species (ROS) and elevated the expression 
of the tumor-suppressor protein p53. Interestingly, walsuronoid 
B (at the intraperitoneal dose of 4 mg/kg) displayed a marked 
anticancer activity in mice with xenografted HepG2 liver 
tumors, with an efficacy comparable to that of the standard 
drug cisplatin (Geng et al., 2017). The activation of the ROS/
Figure 1: The plant Walsura robusta Roxb. (Meliaceae) and its 
geographic breakdown. (a) the tree. (b) leaves and fruits (http://
tracuuduoclieu.vn/walsura-robusta-roxb.html). (c) The plant can be 
found in Vietnam, Laos, Cambodia, Thailand, Myanmar, Malaysia, 
Bhutan, Bangladesh, and in provinces of south China (Yunnan, 
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Figure 2: Chemical structures of selected natural products isolated from Walsura robusta Roxb
Figure 3: Schematic representation of (a) the anticancer activity of walsuronoid B and (b) the anti-inflammatory action of walrobsin M. Walsuronoid 
B activates the production of reactive oxygen species (ROS) and the tumor suppressor protein p53, leading to apoptotic cell death (Geng et al., 
2017). Walrobsin M represses the expression of the phosphorylated signaling proteins ERK (extracellular signal-regulated kinase) and p38 in THP-
1-like macrophages (stimulated with the skin pathogen Propionibacterium acnes), thereby inhibiting the MAPK signaling pathway (An et al., 2019)
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p53 signaling pathway is central to the mechanism of action of 
walsuronoid B, as it is the case for other anticancer plant natural 
products like the cardiac glycoside odoroside A from the plant 
Nerium oleander Linn. (Chen et al., 2019), betulinic acid (Shen 
et al., 2017) and gambogic acid (Liang and Zhang, 2016) for 
examples. There is no doubt that walsuronoid B warrants further 
studies to better define its mode of anticancer action, tumor 
selectivity and molecular targets.
Another small group of limonoids isolated from W. robusta has 
been named walsunoids A-I, isolated together with different 
cedrelone-type limonoids such as 11β-hydroxyisowalsuranolide 
and 11β-hydroxydihydrocedrelone (Wang et al., 2016). These 
compounds were tested against the human 11β-hydroxysteroid 
dehydrogenase type 1 (11β-HSD1), the enzyme which reduces 
inert cortisone into active cortisol, and which is frequently 
implicated in metabolic diseases (obesity, diabetes). A modest 
inhibition of human 11β-HSD1 was observed with walsunoid 
H (Fig. 2) in vitro (IC50 = 9.9 µM) (Wang et al., 2016).
Two other analogues with an atypical 5-oxatricyclo[5.4.11,4]
hendecane ring system have been isolated from the root bark 
of the plant. They were named walrobsins A and B (Fig. 2). 
These two compounds showed no cytotoxic activity, but a 
modest anti-inflammatory activity was reported with walrobsin 
A. The compound was found to inhibit the release of the pro-
inflammatory cytokine interleukin-1β from lipopolysaccharide-
activated RAW264.7 macrophages and to dose-dependently 
inhibit the expression of the inducible nitric oxide synthase 
(iNOS) enzyme, the enzyme responsible for nitric oxide (NO) 
production (An et al., 2017). A subsequent phytochemical 
analysis from the root bark of W. robusta led to the identification 
of other compounds with a 5-oxatricyclohendecane ring system 
and named walrobsins C-to-R (An et al., 2019). The bioactivity 
of these compounds has not been deeply investigated but a 
preliminary evaluation indicated that walrobsin M (Fig. 3b) 
presents an interesting anti-inflammatory profile, with a drug-
induced down-regulation of the expression of protein phospho-
ERK and phospho-p38 in inflamed THP-1 macrophage cells 
(An et al., 2019).
The fruits of the plant also contain a series of compounds 
structurally similar to cedrelone (Fig. 2) and dihydrocedrelone, 
which were found to potentiate the cytotoxicity of the 
anticancer drug doxorubicin in human MCF-7/DOX breast 
cancer cells, normally resistant to the drug. These compounds 
could efficiently reverse the multidrug resistance (MDR) 
phenotype in vitro (Zhang et al., 2017). Cedrelone limonoids 
have been isolated from W. robusta, W. yunnanensis (Ji et al., 
2014), Toona sinensis (Jiang et al., 2020) and from the leaves of 
Trichilia americana, another plant of the Meliaceae family (Ji 
et al., 2015). Acetylation of the cedrelone core affords cedrelone 
acetate, a synthetic molecule presenting enhanced cytotoxic 
properties and efficient to revert the malignant phenotype 
of cancer cells (Becceneri et al., 2020). Cedrelone itself is an 
interesting anticancer agent because this compound was found 
to activate the expression of the protein PBLD (phenazine 
biosynthesis-like domain-containing protein) which is often 
down-regulated in hepatocellular carcinoma (HCC) (Wu 
et al., 2019). PBLD functions as a tumor suppressor. An 
increase of the expression of PBLD could reduce HCC cell 
growth and invasion via inactivation of several tumorigenesis-
related signaling pathways (Li et al., 2016). Through the 
activation of PBLD in cells, cedrelone regulates the Ras and 
Ras-proximate-1 (Rap1) signaling pathways and this signaling 
action triggers apoptosis of cancer cell, while reducing cell 
proliferation and the epithelialmesenchymal transition (Wu 
et al., 2019). The antitumor capacity of cedrelone has been 
characterized in different experimental models, notably 
using drug-resistant human glioma cells (Cao et al., 2019) 
and leukemia cells (Wang et al., 2019). In both cases, the 
compound selectively affected the ERK/MAPK signaling 
pathway. A direct interaction of cedrelone with the ERK1 
kinase has been postulated, based on a computational docking 
analysis. The compound was predicted to bind to a small 
pocket on the protein, leading to the kinase activation (Fig. 4). 
Similarly, a combination of docking and molecular dynamic 
simulations has suggested that cedrelone could bind to the 
multi domain ceramide transfer protein (CERT), a protein 
implicated in sphingolipid metabolism and which allows the 
transport of ceramide from the endoplasmic reticulum to 
the Golgi apparatus (Fig. 4). Cedrelone would bind to the 
linked PH and START domains of CERT, thereby inhibiting 
the protein (Ghoula et al., 2020). Inhibition of CERT is 
considered as an appropriate mechanism to re-sensitize 
cancer cells to chemotherapy (Palau et al., 2018; Kumagai and 
Hanada, 2019). The anticancer effects of cedrolone have been 
evidenced using other cell types, including MDA-MB-231 
breast cancer cells, NCI-H460 non-small cell lung cancer cells 
and A375 melanoma cells (Cazal et al., 2010; Fuzer et al., 
2013). Cedrolone is an interesting natural product which also 
displays anti-fungal and insecticidal activities (Govindachari 
et al., 1995, 2000). It exhibits a sub-micromolar activity 
against the protozoan parasite Cryptosporidium parvum in 
vitro (EC50 = 0.27 µM) (Jin et al., 2019) and causes lethal 
and sublethal effects on the armyworm Spodoptera frugiperda 
(Giongo et al., 2016).
Other terpenes and sesquiterpenes have been isolated from 
W. robusta, such as the carotane sesquiterpene 10-oxo-isodauc-
3-en-15-al (Fig. 2) and its nitro derivative, both isolated from a 
methanolic extract of the plant leaves. These two compounds 
showed no antimicrobial activity against Staphylococcus aureus 
and different MRSA strains (Hou et al., 2013). It is worth to 
note that this isodaucane type sesquiterpenoid can also be 
found in the leaves of the sunflower crop (Helianthus annuus 
L.) and it has revealed a significant herbicidal activity. Indeed, 
10-oxo-isodauc-3-en-15-al was found to inhibit coleoptile 
elongation and is considered as a useful allelopathic compound 
(Fuentes-Gandara et al., 2019). It has been found in diverse 
plants, such as Senecio crassiflorus (Pox.) De Candolle (Jares 
and Pomillo, 1989), Uvaria lucida (Moriyasu et al., 2012), 
Chromolaena laevigata (Misra et al., 1985) and Conza linifolia 
(Hussein et al., 1995). Surprisingly, this compound and its 
C-10 epimer which is known as sinulin A, can be found also 
in a marine organism, the Xisha soft coral Sinularia sp. (Qin 
et al., 2018).
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CONCLUSION
Plants of the Walsura genus have been little studied thus far. 
For examples, the PubMed data bank comprises 30 references 
with the name Walsura, compared to >2000, 300 and 150 
for the genera Trichilia, Aglaia and Xylocarpus, which also 
belong to the Meliaceae family (as of April 2021). Moreover, 
in the Walsura genus, the specie W. pinnata Hassk (synonyms: 
W. cochinchinensis (Baill.) Harms and W. yunnanensis C.Y. Wu) 
is more frequently studied than W. robusta Roxb. This is perhaps 
not surprising because the plant is not so frequently used in 
traditional medicine, except in very local areas. W. robusta trees 
should be investigated further, for the usefulness of their woods 
and the diversity of the secondary metabolites which can be 
isolated from the bark, leaves and fruits of the plant.
As presented here, W. robusta Roxb. provides a rich reservoir of 
limonoids, a huge family of natural products widely distributed 
in nature. Limonoids can be isolated from many plants, and 
some of them can be (semi) synthesized (Zhang and Xu, 2017; 
Fu and Liu, 2020). They are particularly abundant in Meliaceae 
(Tan and Luo, 2011). The great majority of the new natural 
products isolated from W. robusta over the past few years are 
limonoids, such as the walsuronoids, walrobsins, walsurins, and 
walsunoids. Beyond the isolation and characterization of these 
compounds, the bioactivity measurements have been limited 
mainly to a few preliminary in vitro tests, notably to evaluate 
their antimicrobial activity. No outstanding activity has been 
reported, but occasionally a few compounds revealed a modest 
antibacterial or anti-inflammatory effect. Two compounds 
emerge from this literature survey: walsuronoid B and cedrelone, 
because they both present noticeable anticancer properties 
against multiple cancer cell lines. Walsuronoid B stands as a 
potent anticancer agent active in a xenograft model in vivo and 
cedrelone also displays marked anticancer activities. They both 
impact mitochondrial activities, cause an increase of ROS in 
cells, and trigger apoptosis of cancer cells (Geng et al., 2017; 
Cao et al., 2019). They could be considered as prototypes for the 
design of novel anticancer derivatives (Becceneri et al., 2020).
Plants of the Walsura genus, and the specie W. robusta Roxb. 
in particular, have received little attention thus far. This robust 
tree, well distributed in south Asia, should be considered 
further in the search of natural products of medicinal interest. 
We can certainly recommend the investigation of extracts of 
the plant and its abundant fruits, for the treatment of cancers, 
and possibly other diseases with a cell proliferation component. 
The specie deserves its named “robusta”, as a robust provider 
of bioactive limonoids.
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